adjuvant chemotherapy
PURPOSE: To determine the role of the two angiogenic peptides, vascular       endothelial growth factor (VEGF) and thymidine phosphorylase (TP) (the latter       also being a target enzyme for cytotoxicity of 5-fluorouracil and methotrexate),        and conventional prognostic factors in predicting relapse-free survival (RFS) and       overall survival (OS) probabilities in two cohorts of patients with node-positive       breast cancer (NPBC) treated with either adjuvant chemotherapy (CMF       [cyclophosphamide, methotrexate, 5-fluorouracil] schedule) or hormone therapy       (tamoxifen).
PURPOSE: To determine the role of the two angiogenic peptides, vascular       endothelial growth factor (VEGF) and thymidine phosphorylase (TP) (the latter       also being a target enzyme for cytotoxicity of 5-fluorouracil and methotrexate),        and conventional prognostic factors in predicting relapse-free survival (RFS) and       overall survival (OS) probabilities in two cohorts of patients with node-positive        @OBJECT$  (NPBC)  @PREDICAT$  with either  @SUBJECT$  (CMF       [cyclophosphamide, methotrexate, 5-fluorouracil] schedule) or hormone therapy       (tamoxifen).